The Latest Breaking News from Moderna

The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumours

Media outlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

Social media users shared a range of false claims this week

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.